NUR 557 Module 6 Case Paper Example

Acid, Bacteria and a Broken Barrier: Joining a Duodenal Ulcer to Bismuth Quadruple Therapy

[Student Name]

Southern New Hampshire University

NUR 557: Advanced Pathophysiology and Pharmacology Across the Lifespan

Case Paper

[Instructor Name]

[Date]

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

Acid, Bacteria and a Broken Barrier: Joining a Duodenal Ulcer to Bismuth Quadruple Therapy

A peptic ulcer forms when the forces that damage the lining of the stomach or duodenum overwhelm the forces that protect it. Acid and pepsin are the damaging forces; mucus, bicarbonate, blood flow and prostaglandins are the protective ones. Most duodenal ulcers have a clear tipping factor, infection with Helicobacter pylori, often joined by anti-inflammatory drugs. This paper argues that bismuth quadruple therapy works because its four drugs attack the problem at different points, suppressing acid, killing the organism with two antibiotics to which resistance is uncommon and adding bismuth's own antibacterial action, and that removing ibuprofen is the fifth, easily forgotten part of treatment.

The Case

This composite 45-year-old works as a bus mechanic and for six weeks has had a burning ache high in the abdomen, arriving a few hours after he eats, often wakes him around 2 a.m. and eases briefly when he eats. He takes ibuprofen 400 mg several times a week for back pain. A stool antigen test is positive for H. pylori, and endoscopy shows a clean-based ulcer in the duodenal bulb without bleeding. He drinks two or three beers most weekends and has no drug allergies. He has never been treated for H. pylori.

How H. pylori Causes a Duodenal Ulcer

H. pylori survives in the acidic stomach by producing urease, which converts urea into ammonia and buffers the acid around the organism, and it shelters in the mucus layer near the surface cells. In the gastric antrum, the infection reduces the somatostatin-producing cells that normally restrain gastrin release; gastrin rises and drives the parietal cells to secrete more acid. More acid reaches the duodenum, where patches of the duodenal lining change to gastric-type cells that H. pylori can then colonize, bringing inflammation to the very site the acid is attacking (Malfertheiner et al., 2022).

Ibuprofen adds a second blow. By inhibiting cyclooxygenase-1, it reduces prostaglandins that normally maintain mucus and bicarbonate secretion and blood flow in the lining, weakening defense just as acid exposure rises (Rosenthal & Burchum, 2021). The pain pattern fits the site: a duodenal ulcer tends to hurt once the stomach has emptied and overnight, when acid enters the duodenum with no food left to absorb it, and it eases when food arrives.

Placing the Four Drugs on the Mechanism

Current U.S. guidance recommends 14 days of bismuth quadruple therapy for patients never treated for H. pylori when antibiotic susceptibility is unknown, because resistance to clarithromycin, once a mainstay, has become common (Chey et al., 2024). Table 1 shows what each drug contributes.

Table 1

The Four Drugs in Bismuth Quadruple Therapy and What Each Does

The proton pump inhibitor matters beyond healing. Proton pumps are active only when parietal cells are stimulated, so the drug works best taken 30 to 60 minutes before a meal, when food is about to switch the pumps on. Raising gastric pH also slows the breakdown of acid-sensitive antibiotics and may make H. pylori more susceptible to them. The two antibiotics act on different bacterial targets, so an organism resistant to one is still likely to be killed by the other, and the addition of bismuth gives a third antibacterial action. Taken together, the regimen is built to succeed even when resistance patterns are unknown (Malfertheiner et al., 2022).

Teaching That Follows From the Drugs

Each drug's properties shape the teaching. He should take the proton pump inhibitor before breakfast and dinner. Bismuth turns stools and sometimes the tongue black, a harmless effect worth mentioning in advance so it is not mistaken for bleeding; if bismuth subsalicylate is used, it contains salicylate, which matters for anyone with aspirin sensitivity. Tetracycline should be taken with water and not with dairy products, antacids or iron, which bind it and reduce absorption, and it should not be taken lying down, since it can injure the esophagus. Metronidazole can cause a metallic taste and, with alcohol, flushing, nausea and vomiting, so he must avoid alcohol during treatment and for a few days after (Rosenthal & Burchum, 2021). The regimen is demanding, with many pills several times a day for two weeks, so adherence is the biggest threat to cure; a written schedule and a check-in call help.

If the Patient Were Different

The same mechanism-based reasoning shows how the plan would change for other patients. For a pregnant woman or a child under eight, tetracycline is avoided because it binds to developing teeth and bone, so a different regimen would be chosen. For someone who cannot abstain from alcohol, the metronidazole reaction makes adherence risky, which argues for an alternative such as a rifabutin-based regimen listed in the guideline (Chey et al., 2024). For an older adult taking warfarin, metronidazole's inhibition of warfarin metabolism could raise the INR, so closer monitoring would be needed. None of these applies to this patient, but thinking them through shows that each drug in the regimen is chosen for a reason that could change.

Removing the Second Cause and Confirming Cure

Curing the infection is not enough if ibuprofen continues. He should stop it; acetaminophen and non-drug approaches can manage his back pain, and if an anti-inflammatory drug becomes necessary later, it should be paired with ongoing acid suppression. Guidelines recommend confirming eradication by a breath test for urease activity or a repeat stool antigen at least four weeks after finishing antibiotics, with the proton pump inhibitor stopped for about two weeks beforehand, because acid suppression can suppress the organism enough to produce a falsely negative result (Chey et al., 2024). The timing of the test follows directly from how the drugs affect the organism.

Conclusion

This patient's ulcer formed where H. pylori-driven acid met a lining weakened by ibuprofen. Bismuth quadruple therapy works because each drug attacks a different part of that picture: the proton pump inhibitor lowers acid and helps the antibiotics, bismuth, tetracycline and metronidazole kill the organism by different routes, and together they succeed when resistance is unknown. Stopping ibuprofen removes the second cause, and a correctly timed test of cure confirms success. Understanding where each drug acts is also what makes the teaching specific.

References

Chey, W. D., Howden, C. W., Moss, S. F., Morgan, D. R., Greer, K. B., Grover, S., & Shah, S. C. (2024). ACG clinical guideline: Treatment of Helicobacter pylori infection. American Journal of Gastroenterology, 119(9), 1730-1753. https://doi.org/10.14309/ajg.0000000000002968

Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., Rugge, M., Suerbaum, S., Tilg, H., Sugano, K., & El-Omar, E. M. (2022). Management of Helicobacter pylori infection: The Maastricht VI/Florence consensus report. Gut, 71(9), 1724-1762. https://doi.org/10.1136/gutjnl-2022-327745

Rosenthal, L. D., & Burchum, J. R. (2021). Lehne's pharmacotherapeutics for advanced practice nurses and physician associates (2nd ed.). Elsevier.